A substantial advancement in diabetes management is emerging with the approval of tirzepatide at a dosage of 45mg. This updated offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, https://annieuvlv418101.azuria-wiki.com/2243857/revolutionary_development_tirzepatide_45mg_for_diabetes_regulation